Publications

Publications​​

CV

*Authors contributed equally to these works

†Shared corresponding author position

  1. Mullowney MW, Maltseva NI, Endres M, Kim Y, Joachimiak A, Crofts TS†,(2022) Functional and structural characterization of diverse NfsB chloramphenicol reductase enzymes from human pathogens. Microbiology Spectrum, 10 (2). e00139-22. [PDF]
  2. Crofts TS†, McFarland AG, Hartmann EM (2021) Mosaic Ends Tagmentation (METa) assembly for extremely efficient construction of functional metagenomic libraries. mSystems, 6 (3). e00524-21. [PDF]
  3. Crofts TS†, Sontha P, King OA, Wang B, Biddy BA, Zanolli N, Gaumnitz J, Dantas G (2019) Discovery and characterization of a nitroreductase capable of conferring bacterial resistance to chloramphenicol. Cell Chemical Biology 26 (4). 559-70.[PDF]
  4. Crofts TS, Wang B, Spivak A, Gianoulis TA, Forsberg KJ, Gibson MK, Johnsky LA, Broomall SM, Rosenzweig CN, Skowronski EW, Gibbons HS, Sommer MOA, Dantas G (2018) Shared strategies for β-lactam catabolism in the soil microbiome. Nature Chemical Biology, 14 (6). 556-64.[PDF]
  5. Keen EC*, Crofts TS*, Dantas G (2018) Checkpoint checkmate: Microbiota modulation of cancer immunotherapy. Clinical Chemistry, 64 (9). 1280-3.[PDF]
  6. Crofts TS, Wang B, Spivak A, Gianoulis TA, Forsberg KJ, Gibson MK, Johnsky LA, Broomall SM, Rosenzweig CN, Skowronski EW, Gibbons HS, Sommer MOA, Dantas G (2017) Draft genome sequences of three β-lactam-catabolizing soil Proteobacteria. Genome Announcements, 5 (32). 8-10.[PDF]
  7. Crofts TS*, Gasparrini AJ*, Dantas G (2017) Next-generation approaches to understand and combat the antibiotic resistome. Nature Reviews Microbiology, 15 (7), 422-34.[PDF]
  8. Gasparrini AJ*, Crofts TS*, Gibson MK, Tarr PI, Warner BB, Dantas G (2016) Antibiotic perturbation of the preterm infant gut microbiome and resistome. Gut Microbes, 7 (5), 443-9.[PDF]
  9. Gibson MK*, Crofts TS*, Dantas G (2015) Antibiotics and the developing infant gut microbiota and resistome. Current Opinion in Microbiology, 27, 51-6.[PDF]
  10. Crofts TS*, Hazra AB*, Tran JLA, Sokolovskaya O, Osadchiy V, Ad O, Pelton J, Bauer S, Taga ME (2014) Regiospecific formation of cobamide isomers is directed by CobT. Biochemistry, 53 (49), 7805-15.[PDF]
  11. Crofts TS, Men Y, Alvarez-Cohen L, Taga ME (2014) A bioassay for the detection of benzimidazoles reveals their presence in a range of environmental samples. Frontiers in Microbiology. 5:592.[PDF]
  12. Men Y, Seth EC, Yi S, Crofts TS, Allen RH, Taga ME, Alvarez-Cohen L (2014) Identification of specific corrinoids reveals corrinoid modifications in dechlorinating microbial communities. Environmental Microbiology, 17 (12), 4873-84.[PDF]
  13. Crofts TS, Seth EC, Hazra AB, Taga ME (2013) Cobamide structure depends on both lower ligand availability and CobT substrate specificity. Chemistry and Biology, 20 (10), 1265-74.[PDF]
  14. Hazra AB, Tran JLA, Crofts TS, Taga ME (2013) Analysis of substrate specificity in CobT homologs reveals widespread preference for 5,6-dimethylbenzimidazole, the lower axial ligand of vitamin B12. Chemistry and Biology, 20 (10), 1275-85.[PDF]
  15. Bowerman NA, Crofts TS, Chlewicki L, Do P, Baker BM, Garcia KC, Kranz DM (2009). Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity. Molecular Immunology, 46 (15), 3000-8.[PDF]
    16. ​
Popular press
  1. Crofts, Terence S. “Bacteria may be powerful weapon against antibiotic resistance.” The Conversation, May 2nd, 2018,theconversation.com/bacteria-may-be-powerful-weapon-against-antibiotic-resistance-95750.